|
|
|
|
|||||||||
|
|
Mission StatementDiaKine’s mission is to develop novel therapies that address unmet medical needs in type 1 and type 2 diabetes, by uniquely preventing inflammatory damage to insulin producing cells in islets and blocking complications that result from diabetes.
|
||||||||||
|
|
|
|
|
||||||||
|
©2006 DiaKine Therapeutics. All rights reserved.
|
|||||||||||